{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T05:51:23Z","timestamp":1658555483980},"reference-count":23,"publisher":"The Japan Geriatrics Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2022,4,25]]},"DOI":"10.3143\/geriatrics.59.237","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:12:18Z","timestamp":1654121538000},"page":"237-243","source":"Crossref","is-referenced-by-count":1,"title":["Switching insulin degludec to insulin glulisine improved nocturnal hypoglycemia and ventricular arrythmia in an elderly type 1 diabetes patient with chronic heart failure: A case report"],"prefix":"10.3143","volume":"59","author":[{"given":"Yuriko","family":"Hajika","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Minami Osaka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Minami Osaka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Minami Osaka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hamazaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Minami Osaka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuro","family":"Kumeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Minami Osaka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, et al.: Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial. Diabetes care 2014; 37: 634-643.","DOI":"10.2337\/dc13-1545"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kim Y-G, Park DG, Moon SY, Jeon JY, Kim HJ, Kim DJ, et al.: Hypoglycemia and dementia risk in older patients with type 2 diabetes mellitus: a propensity-score matched analysis of a population-based cohort study. Diabetes Metab 2020; 44: 125-133.","DOI":"10.4093\/dmj.2018.0260"},{"key":"3","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2337\/dc18-0559","volume":"41","author":"J Rosenstock","year":"2018","unstructured":"3) Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, et al.: More similarities than differences testing insulin glargine 300 units\/mL versus insulin degludec 100 units\/mL in insulin-naive type 2 diabetes: the randomized head-to-head BRIGHT trial. Diabetes care 2018; 41: 2147-2154.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Siegmund T, Tentolouris N, Knudsen ST, Lapolla A, Prager R, Phan TM, et al.: AE uropean, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes. Diabetes Obes Metab 2018; 20: 689-697.","DOI":"10.1111\/dom.13149"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sullivan SD, Nicholls CJ, Gupta RA, Menon AA, Wu J, Westerbacka J, et al.: Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units\/mL or insulin degludec: The DELIVER Na\u00efve D real-world study. Diabetes Obes Metab 2019; 21: 2123-2132.","DOI":"10.1111\/dom.13793"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kawaguchi Y, Sawa J, Sakuma N, Kumeda Y: Efficacy and safety of insulin glargine 300 U\/mL vs insulin degludec in patients with type 2 diabetes: a randomized, open-label, cross-over study using continuous glucose monitoring profiles. J Diabetes Investig 2019; 10: 343-351.","DOI":"10.1111\/jdi.12884"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamabe M, Kuroda M, Hirosawa Y, Kamino H, Ohno H, Yoneda M: Comparison of insulin glargine 300 U\/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study. J Diabetes Investig 2019; 10: 352-357.","DOI":"10.1111\/jdi.12894"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) \u5c0f\u5009\u96c5\u4ec1, \u539f\u5cf6\u4f38\u4e00, \u897f\u6751\u4e9c\u5e0c\u5b50, \u7a32\u57a3\u66a2\u4e5f: \u30a4\u30f3\u30b9\u30ea\u30f3\u30c7\u30b0\u30eb\u30c7\u30af\u3092\u4f7f\u7528\u4e2d\u306b\u91cd\u75c7\u4f4e\u8840\u7cd6\u3092\u304d\u305f\u3057\u305f2\u4f8b. \u7cd6\u5c3f\u75c5 2015; 58: 702-706.","DOI":"10.11213\/tonyobyo.58.702"},{"key":"9","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-010-1752-6","volume":"53","author":"C Nordin","year":"2010","unstructured":"10) Nordin C: The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 2010; 53: 1552-1561.","journal-title":"Diabetologia","ISSN":"http:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"key":"10","unstructured":"11) \u4e00\u822c\u793e\u56e3\u6cd5\u4eba \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a, \u4e00\u822c\u793e\u56e3\u6cd5\u4eba \u65e5\u672c\u8001\u5e74\u533b\u5b66\u4f1a: \u9ad8\u9f62\u8005\u7cd6\u5c3f\u75c5\u6cbb\u7642\u30ac\u30a4\u30c92021, \u7b2c1\u7248, \u6587\u5149\u5802, \u6771\u4eac, 2021, p35-41."},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2013; 369: 362-372.","DOI":"10.1056\/NEJMra1215228"},{"key":"12","unstructured":"13) Cryer P: Hypoglycemia in diabetes: pathophysiology, prevalence and prevention, 2nd ed, American Diabetes Association, Alexandria, VA, 2012."},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Cryer PE: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350: 2272-2279.","DOI":"10.1056\/NEJMra031354"},{"key":"14","doi-asserted-by":"publisher","unstructured":"15) \u677e\u4e0b\u7531\u7f8e, \u9ad8\u7530\u5eb7\u5fb3, \u677e\u7530 \u85cd, \u5ddd\u6751\u826f\u4e00, \u5927\u6cbc \u88d5, \u5927\u6fa4\u6625\u5f66: \u6301\u7d9a\u8840\u7cd6\u30e2\u30cb\u30bf\u30fc\u3068\u30db\u30eb\u30bf\u30fc\u5fc3\u96fb\u56f3\u306b\u3088\u308a\u591c\u9593\u4f4e\u8840\u7cd6\u6642\u306e\u81ea\u5f8b\u795e\u7d4c\u6d3b\u52d5\u5909\u5316\u3092\u89e3\u6790\u3057\u5f97\u305f1\u578b\u7cd6\u5c3f\u75c5\u306e1\u4f8b. \u7cd6\u5c3f\u75c5 2016; 59: 475-481.","DOI":"10.11213\/tonyobyo.59.475"},{"key":"15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","volume":"26","author":"C Desouza","year":"2003","unstructured":"16) Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V: Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes care 2003; 26: 1485-1489.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"16","unstructured":"17) \u68ee  \u8c4a: \u98df\u5f8c\u9ad8\u8840\u7cd6\u7ba1\u7406\u306b\u304a\u3051\u308bCGM\u306e\u9069\u5fdc\u30fb\u89e3\u91c8\u30fb\u6709\u7528\u6027 -\u98df\u5f8c\u304b\u3089\u591c\u9593\u6df1\u591c\u5e2f\u3078\u306e\u8840\u7cd6\u5909\u52d5\u30fb\u4ea4\u611f\u795e\u7d4c\u6d3b\u52d5\u30fb\u8840\u5727\u5909\u52d5\u306e\u8996\u70b9\u304b\u3089-. \u6708\u520a\u7cd6\u5c3f\u75c5 2013; 12: 32-44."},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Kawaguchi Y, Sawa J, Hamai C, Kumeda Y: Differential effect of hypoalbuminemia on hypoglycemia on type 2 diabetes patients treated with insulin glargine 300 U\/ml and insulin degludec. Diabetes Ther 2019; 10: 1535-1541.","DOI":"10.1007\/s13300-019-0654-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Haahr H, Heise T: A review of the pharmacological properties of insulin degludec and their clinical relevance. Clin Pharmacokinet 2014; 53: 787-800.","DOI":"10.1007\/s40262-014-0165-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Bailey T, Pettus J, Roussel R, Schmider W, Maroccia M, Nassr N, et al.: Morning administration of 0.4 U\/kg\/day insulin glargine 300 U\/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U\/mL in type 1 diabetes. Diabetes Metab 2018; 44: 15-21.","DOI":"10.1016\/j.diabet.2017.10.001"},{"key":"20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/dc14-0006","volume":"38","author":"RH Becker","year":"2015","unstructured":"21) Becker RH, Dahmen R, Bergmann K, Lehmann A, Jax T, Heise T: New insulin glargine 300 units\u00b7 mL<sup>\u22121<\/sup> provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units\u00b7 mL<sup>\u22121<\/sup>. Diabetes care 2015; 38: 637-643.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Caprio S, Amiel S, Tamborlane WV, Gelfand RA, Sherwin RS: Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia: influence of glycemic control. Dia 1990; 39: 134-141.","DOI":"10.2337\/diabetes.39.2.134"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, et al.: Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 1995; 312: 725-731.","DOI":"10.1042\/bj3120725"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S: The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther 2015; 17: 787-794.","DOI":"10.1089\/dia.2014.0378"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/59\/2\/59_59.237\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T04:47:53Z","timestamp":1654318073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/59\/2\/59_59.237\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.59.237","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"59.237"}}